EN
HI
Syncom Formulations (India) Chart
Syncom Formulations (India) Share Key Metrics
Volume
31.51 L
Market Cap
1274.64 CR
LTQ@LTP
162@13.56
ATP
13.61
Var Margin
21.18 %
Circuit Range
10.4-15.58
Delivery %
44.1 %
Value
4.29 CR
ASM/GSM
No
Market Lot
1
Summary
At 10 Apr, 2026 | 15:50, Syncom Formulations (India) share price stands at ₹13.56, showing a 0.57% 4.39 for the day. The stock’s intraday movement has stayed between ₹13.16 and ₹13.93, while on a 52-week basis it has fluctuated from ₹10.21 to ₹23.49.
In terms of trading activity, Syncom Formulations (India) has recorded a volume of 3150759 shares, with a market capitalisation of ₹940000000. The stock’s Average Traded Price (ATP) stands at ₹1361, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 162,1356. The stock operates within a circuit range of ₹10.4-15.58, with a Value of ₹4.29 CR. The Delivery Percentage for the day is 44.1%. Additionally, Syncom Formulations (India) currently falls under the No framework, and trades with a market lot size of 1.
Syncom Formulations (India) Fundamentals
View MoreP/E Ratio
17.72
P/B Ratio
3.08
Div. Yield
0
Sector P/E
62.26
Sector P/B
3.36
Sec. Div. Yield
0.58
Syncom Formulations (India) Resistance and Support
Pivot 13.06
Resistance
First Resistance
13.3
Second Resistance
13.62
Third Resistance
13.86
Support
First Support
12.74
Second Support
12.5
Third Support
12.18
Syncom Formulations (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-10 | Quarterly Results & Others |
Syncom Formulations (India) News
Syncom Formulations (India) Limited
Syncom Formulations' promoters and Persons Acting in Concert submitted their yearly disclosure for the financial year ended March 31, 2026, to the Audit Committee. This regulatory filing confirms no undisclosed encumbrances on the company's securities, ensuring compliance with SEBI regulations.
Apr 06 2026 17:04:00
Read More
About Syncom Formulations (India)
NSE : 11992
BSE : 524470
ISIN : INE312C01025
Syncom Formulations (India) Management
| Name | Position |
|---|---|
| Mr. Ankit Kedarmal Bankda | Executive Chairman & Whole-time Director |
| Mr. Vijay Shankarlal Bankda | Managing Director |
Syncom Formulations (India) Similar Stocks
NGL Fine-Chem Ltd.
2331.20
-30.60 (1.30%)
Suraksha Diagnostic Ltd.
275.15
11.71 (4.45%)
Ind-Swift Laboratories Ltd.
140.57
-2.66 (1.86%)
Venus Remedies Ltd.
994.10
17.15 (1.76%)
Hester Biosciences Ltd.
1454.60
26.10 (1.83%)
Sakar Healthcare Ltd.
589.45
17.10 (2.99%)
Bajaj Healthcare Ltd.
337.60
13.55 (4.18%)
Lincoln Pharmaceuticals Ltd.
578.10
30.25 (5.52%)
GPT Healthcare Ltd.
139.98
3.03 (2.21%)
Syncom Formulations (India) FAQs
The Buying Price of Syncom Formulations (India) share is 13.56 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Syncom Formulations (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Syncom Formulations (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Syncom Formulations (India) shares is 17.72. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Syncom Formulations (India) shares is 3.08. Useful to assess the stock's value relative to its book value.
To assess Syncom Formulations (India)’s valuation compare Sector P/E, P/B which are 62.26 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Syncom Formulations (India) is 1274.64 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Syncom Formulations (India) share price is 23.49 & 10.21. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Syncom Formulations (India) belongs to the Healthcare sector.
